These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17390404)

  • 1. Antipsychotic drugs: the costs and benefits.
    Harv Ment Health Lett; 2007 Mar; 23(9):5-6. PubMed ID: 17390404
    [No Abstract]   [Full Text] [Related]  

  • 2. Policy toward second-generation antipsychotic drugs: a cautionary note.
    Frank RG
    Psychiatr Serv; 2008 May; 59(5):521-2. PubMed ID: 18451008
    [No Abstract]   [Full Text] [Related]  

  • 3. [Expensive but nevertheless cost effect? Pharmacoeconomics of atypical neuroleptics].
    Laux G; Günther W
    Pharm Unserer Zeit; 2002; 31(6):572-6. PubMed ID: 12481515
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-benefits of new drugs.
    Daniel DG; Moseley C; Rosenfield S; Wolf S; Nawroz S
    Psychiatr Serv; 1995 Aug; 46(8):835-6. PubMed ID: 7583490
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness of schizophrenia pharmacotherapy.
    Soumerai SB; Law MR
    Am J Psychiatry; 2007 Apr; 164(4):678; author reply 678-9. PubMed ID: 17403984
    [No Abstract]   [Full Text] [Related]  

  • 6. The NIMH-CATIE Schizophrenia Study: what did we learn?
    Lieberman JA; Stroup TS
    Am J Psychiatry; 2011 Aug; 168(8):770-5. PubMed ID: 21813492
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-effectiveness measures, methods, and policy implications from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for schizophrenia.
    Rosenheck RA; Lieberman JA
    J Clin Psychiatry; 2007 Feb; 68(2):e05. PubMed ID: 17335313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which atypical antipsychotic.
    Thomas CS; Lewis S
    Br J Psychiatry; 1998 Feb; 172():106-9. PubMed ID: 9519061
    [No Abstract]   [Full Text] [Related]  

  • 9. Antipsychotic drug use patterns and the cost of treating schizophrenia.
    McCombs JS; Nichol MB; Johnstone BM; Stimmel GL; Shi J; Smith R
    Psychiatr Serv; 2000 Apr; 51(4):525-7. PubMed ID: 10737831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods of pharmacoeconomic evaluation of psychopharmacologic therapies for patients with schizophrenia.
    Revicki DA
    J Psychiatry Neurosci; 1997 Jul; 22(4):256-66. PubMed ID: 9262048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical antipsychotic agents in the treatment of Schizophrenia and other psychiatric disorders. Part II: Special considerations.
    J Clin Psychiatry; 1998 Jun; 59(6):322-8. PubMed ID: 9671350
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug treatments for schizophrenia.
    Adams C; Wilson P; Gilbody S; Bagnall AM; Lewis R
    Qual Health Care; 2000 Mar; 9(1):73-9. PubMed ID: 10848375
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessing a drug's cost-benefits.
    Raleigh F
    Psychiatr Serv; 1996 Aug; 47(8):877-8. PubMed ID: 8837167
    [No Abstract]   [Full Text] [Related]  

  • 14. Perspective and the measurement of costs and benefits for cost-effectiveness analysis in schizophrenia.
    Meltzer D
    J Clin Psychiatry; 1999; 60 Suppl 3():32-5; discussion 36-7. PubMed ID: 10073375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical applications of recent antipsychotic effectiveness data.
    J Clin Psychiatry; 2007 Jan; 68(1):151-62. PubMed ID: 17284143
    [No Abstract]   [Full Text] [Related]  

  • 16. Estimating the costs and benefits of new drug therapies: atypical antipsychotic drugs for schizophrenia.
    Mauskopf J; Muroff M; Gibson PJ; Grainger DL
    Schizophr Bull; 2002; 28(4):619-35. PubMed ID: 12795495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New antipsychotic agents: emerging clinical profiles.
    Buckley PF
    J Clin Psychiatry; 1999; 60 Suppl 1():12-7; discussion 28-30. PubMed ID: 10037165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine and hospitalization.
    Rosenheck R; Charney D; Cramer J
    Psychiatr Serv; 1999 Jan; 50(1):114-6. PubMed ID: 9890595
    [No Abstract]   [Full Text] [Related]  

  • 19. What do large scale studies of medication in schizophrenia add to our management strategies?
    Agius M; Davis A; Gilhooley M; Chapman S; Zaman R
    Psychiatr Danub; 2010 Jun; 22(2):323-8. PubMed ID: 20562774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between costs and symptoms in schizophrenia patients treated with antipsychotic medication: a review.
    Sevy S; Visweswaraiah H; Mentschel C; Leucht S; Schooler NR
    J Clin Psychiatry; 2004 Jun; 65(6):756-65. PubMed ID: 15291652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.